JNJ is a strong dividend king with impressive revenue growth, but its current valuation makes it a hold rather than a buy.
Source Post
Best Dividend King to Own?! | $100B Revenue in 2026 & This Dividend Stock is Up Over 50% in 1 Year
Dividend DiplomatsApr 21, 2026
The Dividend Diplomats discuss Johnson & Johnson (JNJ), highlighting its strong performance over the last year, driven by its focus on pharmaceuticals after splitting off its consumer brands. Despite a recent dividend increase of 3.1%, the stock's price appreciation has led to a lower yield of 2.29%. While the company is on track to exceed $100 billion in revenue by 2026, its P/E ratio of 20 is considered somewhat expensive compared to historical averages.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.